Categories Earnings, Health Care
Earnings Summary: Everything you need to know about IDEXX’s Q4 2023 report
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for the fourth quarter of 2023.
- Fourth-quarter revenues increased 9% annually to $901.6 million; organic revenue growth was 8%
- Net income attributable to shareholders moved up to $194.52 million from $172.2 million a year earlier
- On a per-share basis, fourth-quarter earnings rose to $2.32 per share from $2.05 per share in Q4 2022
- For fiscal 2024, the management expects revenues to be in the range of $3.93 billion to $4.04 billion, reflecting a growth of 7.5-10.5%
- Full-year organic revenue growth is expected to be between 7% and 10%
- The management is looking for earnings of $10.84 per share to $11.33 per share for FY24, an increase of 8-13% as reported and on a comparable basis
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%
